Literature DB >> 19582196

Homocystein and carotid atherosclerosis in chronic renal failure.

M Lubomirova1, A Tzoncheva, J Petrova, B Kiperova.   

Abstract

BACKGROUND: Since total homocysteine (Hcy) is markedly elevated in patients with chronic renal failure (CRF), it has been presented as potential factor contributing to the high risk of cardiovascular disease (CVD) in CRF. The aim of the study was to examine the significance of elevated Hcy and other cardiovascular risk factors for carotid atherosclerosis in patients with CRF.
MATERIAL AND METHODS: Fifty six patients 16-M, 40-F, average age 58+/-14.55, creatinine clearance 39.19+/-10.11 ml/min were examined. In addition, 20 control healthy subjects were examined. The association of Hcy levels and classic risk factors for atherosclerosis with common carotid intima-media thickness (IMT) was examined. B-mode ultrasound measurement of carotid IMT was performed in 56 hypertensive pts with CRF (glomerular filtration rate>20 ml/min and <90 ml/min), 44 hypertensive pts with normal renal function and 20 healthy volunteers. The mean duration of hypertension was 145.12 years.
RESULTS: IMT in all examined hypertensive pts was increased above normal clinical value and significantly higher then in healthy controls (0.75+/-0.006/0.60+/-0.1, p<0.001). The carotid IMT was similar between hypertensive pts with CRF and hypertensive pts with normal renal function (0.74+/-0.1/0.76 +/-0.1, p>0.05). Significant predictors for IMT were age (r=0.358, p<0.04), duration of hypertension (r=0.395, p=0.023), diabetes duration (r=0.343, p<0.02), as well as duration of CRF (r=0.324, p<0.006). There was a negative correlation between IMT and glomerular filtration rate assessed by creatinine clearance (r=-0.303, p<0.003). Renal function, described by creatinine clearance was the strongest determinant for Hcy levels (r=-0.332, p<0.008). Increased IMT was estimated in pts with CRF compared to healthy controls (0.74+/-0.10 vs 0.59+/-0.10, p<0.001). We found association between Hcy and carotid IMT ( r=0.344, p<0.015). No consistent association was found between IMT and other specific for CRF cardiovascular risk factors.
CONCLUSION: The study suggests that patients with mild renal failure have increased IMT of the common carotid artery and that elevated plasma Hcy level in CRF is associated with carotid intima- media thickening.

Entities:  

Keywords:  cardiovascular risk factors; carotid artery; carotid intima- media thickness; chronic renal failure; total homocystein; ultrasound examination

Year:  2007        PMID: 19582196      PMCID: PMC2552986     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  16 in total

1.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.

Authors:  M L Bots; A W Hoes; P J Koudstaal; A Hofman; D E Grobbee
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

2.  Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up.

Authors:  C D Stehouwer; M P Weijenberg; M van den Berg; C Jakobs; E J Feskens; D Kromhout
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-12       Impact factor: 8.311

3.  Enzyme conversion immunoassay for determining total homocysteine in plasma or serum.

Authors:  F Frantzen; A L Faaren; I Alfheim; A K Nordhei
Journal:  Clin Chem       Date:  1998-02       Impact factor: 8.327

Review 4.  Vessel wall alterations in patients with renal failure.

Authors:  K H Rahn; M Barenbrock; M Hausberg; M Kosch; B Suwelack; J Witta
Journal:  Hypertens Res       Date:  2000-01       Impact factor: 3.872

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.

Authors:  A Zanchetti; M G Bond; M Hennig; A Neiss; G Mancia; C Dal Palù; L Hansson; B Magnani; K H Rahn; J Reid; J Rodicio; M Safar; L Eckes; R Ravinetto
Journal:  J Hypertens       Date:  1998-07       Impact factor: 4.844

7.  Homocysteine and carotid atherosclerosis in chronic renal failure--the confounding effect of renal function.

Authors:  Yrjö Leskinen; Terho Lehtimäki; Antti Loimaala; Heini Huhtala; Juha P Salenius; Simo S Oja; Heikki Saha
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

8.  Association between serum homocysteine and markers of impaired kidney function in adults in the United States.

Authors:  Mildred E Francis; Paul W Eggers; Thomas H Hostetter; Josephine P Briggs
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

9.  The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness.

Authors:  A Zanchetti; E A Rosei; C Dal Palù; G Leonetti; B Magnani; A Pessina
Journal:  J Hypertens       Date:  1998-11       Impact factor: 4.844

10.  Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension.

Authors:  Giovanna Leoncini; Francesca Viazzi; Denise Parodi; Simone Vettoretti; Elena Ratto; Maura Ravera; Cinzia Tomolillo; Massimo Del Sette; Gian Paolo Bezante; Giacomo Deferrari; Roberto Pontremoli
Journal:  Hypertension       Date:  2003-05-19       Impact factor: 10.190

View more
  3 in total

Review 1.  Influence of food patterns on endothelial biomarkers: a systematic review.

Authors:  María Daniela Defagó; Natalia Elorriaga; Vilma Edith Irazola; Adolfo Luis Rubinstein
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-11-06       Impact factor: 3.738

2.  Metabolite profiling reveals new insights into the regulation of serum urate in humans.

Authors:  Eva Albrecht; Melanie Waldenberger; Jan Krumsiek; Anne M Evans; Ulli Jeratsch; Michaela Breier; Jerzy Adamski; Wolfgang Koenig; Sonja Zeilinger; Christiane Fuchs; Norman Klopp; Fabian J Theis; H-Erich Wichmann; Karsten Suhre; Thomas Illig; Konstantin Strauch; Annette Peters; Christian Gieger; Gabi Kastenmüller; Angela Doering; Christa Meisinger
Journal:  Metabolomics       Date:  2013-07-20       Impact factor: 4.290

Review 3.  Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression.

Authors:  Krzysztof Laudanski
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.